Indian biotechnology firm Premas Biotech’s joint venture company Oravax Medical is set to begin testing their triple antigen oral vaccine candidate against the new Omicron variant of concern. Oravax Medical is formed by Oramed Pharmaceuticals, […]
Hyundai Bioscience has reported that a combination of the niclosamide-based oral antiviral drug candidate, CP-COV03, with anti-inflammatory therapy, dexamethasone, showed to be effective in people with severe Covid-19 in a study. Developed by the company’s […]
SMi Group reports: The 13th Annual RNA Therapeutics Conference is set to return in February 2022 with a key focus on the latest advances and opportunities in RNA-based medicine. SMi Group is delighted to announce […]
SMi Group reports: Six key presentations featured at the Robotics & Automation in Pharma Conference in London on 21-22 February 2022 SMi Group are delighted to announce the launch of the inaugural Robotics and Automation […]
SMi Group reports: The inaugural Robotics and Automation Conference is convening on 21st and 22nd February 2022,in London, UK, with a key focus on significant leaps in the robotic automation field. SMi Group are delighted […]